Filed: 11/14/2024ACC: 0001389932-24-000020
📋 What this filing means
DAFNA CAPITAL MANAGEMENT LLC filed this quarterly 13F‑HR report disclosing 84 equity positions with a total reported market value of $423.31M. This filing provides a transparent view of the manager's long equity holdings as of the quarter end.
84
Positions
$423.31M
Total AUM (reported)
46.25M
Total Shares
Allocation by class
COM$257.55M60.8%
COM NEW$61.83M14.6%
ETF$54.59M12.9%
SPONSORED ADR$13.37M3.2%
SPONSORED ADS$11.05M2.6%
SHS$6.71M1.6%
NOTE 2.250% 4/0$4.68M1.1%
Portfolio Concentration
Top 3$91.07M21.5%
4–10$115.98M27.4%
11–25$119.03M28.1%
Rest$97.24M23.0%
Top 3 weight
21.5%
Top 10 weight
48.9%
Voting Authority Distribution
Total shares with voting rights: 46.25M
Sole
Full voting authority
46.25M
shares
% of voting shares100.0%
Shared
Joint voting authority
0.00
shares
% of voting shares0.0%
None
No voting authority
0.00
shares
% of voting shares0.0%
Investment Discretion (by position count)
Sole84
Shared0
Other0
Dominant voting typeSole · 100.0% of voting shares
Institutional Holdings84
Rows:
SPDR S&P BIOTECH ETF
SOLEShares401.50K
TypeSH
Market value$39.67M
9.37%
Sole
401.50K
Shared
0.00
None
0.00
STEREOTAXIS INC
SOLEShares13.68M
TypeSH
Market value$27.91M
6.59%
Sole
13.68M
Shared
0.00
None
0.00
REVOLUTION MEDICINES INC
SOLEShares517.99K
TypeSH
Market value$23.49M
5.55%
Sole
517.99K
Shared
0.00
None
0.00
CYTOKINETICS INC
SOLEShares398.10K
TypeSH
Market value$21.02M
4.97%
Sole
398.10K
Shared
0.00
None
0.00
MERUS N V
SOLEShares412.57K
TypeSH
Market value$20.61M
4.87%
Sole
412.57K
Shared
0.00
None
0.00
ATRICURE INC
SOLEShares641.67K
TypeSH
Market value$17.99M
4.25%
Sole
641.67K
Shared
0.00
None
0.00
IDEAYA BIOSCIENCES INC
SOLEShares471.41K
TypeSH
Market value$14.93M
3.53%
Sole
471.41K
Shared
0.00
None
0.00
ISHARES NASDAQ BIOTECH INDX
SOLEShares102.50K
TypeSH
Market value$14.92M
3.53%
Sole
102.50K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares89.57K
TypeSH
Market value$13.37M
3.16%
Sole
89.57K
Shared
0.00
None
0.00
AXOGEN INC
SOLEShares935.89K
TypeSH
Market value$13.12M
3.10%
Sole
935.89K
Shared
0.00
None
0.00
BLUEPRINT MEDICINES CORP
SOLEShares121.76K
TypeSH
Market value$11.26M
2.66%
Sole
121.76K
Shared
0.00
None
0.00
XENON PHARMACEUTICALS INC
SOLEShares273.74K
TypeSH
Market value$10.78M
2.55%
Sole
273.74K
Shared
0.00
None
0.00
DAY ONE BIOPHARMACEUTICALS I
SOLEShares750.36K
TypeSH
Market value$10.45M
2.47%
Sole
750.36K
Shared
0.00
None
0.00
SYNDAX PHARMACEUTICALS INC
SOLEShares526.70K
TypeSH
Market value$10.14M
2.40%
Sole
526.70K
Shared
0.00
None
0.00
BIOHAVEN LTD
SOLEShares187.13K
TypeSH
Market value$9.35M
2.21%
Sole
187.13K
Shared
0.00
None
0.00
TANDEM DIABETES CARE INC
SOLEShares204.21K
TypeSH
Market value$8.66M
2.05%
Sole
204.21K
Shared
0.00
None
0.00
KALVISTA PHARMACEUTICALS INC
SOLEShares723.68K
TypeSH
Market value$8.38M
1.98%
Sole
723.68K
Shared
0.00
None
0.00
NEUROCRINE BIOSCIENCES INC
SOLEShares69.61K
TypeSH
Market value$8.02M
1.89%
Sole
69.61K
Shared
0.00
None
0.00
KURA ONCOLOGY INC
SOLEShares408.37K
TypeSH
Market value$7.98M
1.89%
Sole
408.37K
Shared
0.00
None
0.00
VIKING THERAPEUTICS INC
SOLEShares125.62K
TypeSH
Market value$7.95M
1.88%
Sole
125.62K
Shared
0.00
None
0.00
EDGEWISE THERAPEUTICS INC
SOLEShares227.91K
TypeSH
Market value$6.08M
1.44%
Sole
227.91K
Shared
0.00
None
0.00
UROGEN PHARMA LTD
SOLEShares458.92K
TypeSH
Market value$5.83M
1.38%
Sole
458.92K
Shared
0.00
None
0.00
BIOCRYST PHARMACEUTICALS INC
SOLEShares667K
TypeSH
Market value$5.07M
1.20%
Sole
667K
Shared
0.00
None
0.00
ASCENDIS PHARMA A/S
SOLEShares4M
TypePRN
Market value$4.68M
1.11%
Sole
4M
Shared
0.00
None
0.00
DEXCOM INC
SOLEShares65.55K
TypeSH
Market value$4.39M
1.04%
Sole
65.55K
Shared
0.00
None
0.00
| Issuer | Class | Shares | Type | Value / Portfolio % | Voting — Sole | Shared | None |
|---|---|---|---|---|---|---|---|
SPDR S&P BIOTECH ETFSOLE | ETF | 401.50K | SH | $39.67M 9.37% | 401.50K | 0.00 | 0.00 |
STEREOTAXIS INCSOLE | COM NEW | 13.68M | SH | $27.91M 6.59% | 13.68M | 0.00 | 0.00 |
REVOLUTION MEDICINES INCSOLE | COM | 517.99K | SH | $23.49M 5.55% | 517.99K | 0.00 | 0.00 |
CYTOKINETICS INCSOLE | COM NEW | 398.10K | SH | $21.02M 4.97% | 398.10K | 0.00 | 0.00 |
MERUS N VSOLE | COM | 412.57K | SH | $20.61M 4.87% | 412.57K | 0.00 | 0.00 |
ATRICURE INCSOLE | COM | 641.67K | SH | $17.99M 4.25% | 641.67K | 0.00 | 0.00 |
IDEAYA BIOSCIENCES INCSOLE | COM | 471.41K | SH | $14.93M 3.53% | 471.41K | 0.00 | 0.00 |
ISHARES NASDAQ BIOTECH INDXSOLE | ETF | 102.50K | SH | $14.92M 3.53% | 102.50K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | SPONSORED ADR | 89.57K | SH | $13.37M 3.16% | 89.57K | 0.00 | 0.00 |
AXOGEN INCSOLE | COM | 935.89K | SH | $13.12M 3.10% | 935.89K | 0.00 | 0.00 |
BLUEPRINT MEDICINES CORPSOLE | COM | 121.76K | SH | $11.26M 2.66% | 121.76K | 0.00 | 0.00 |
XENON PHARMACEUTICALS INCSOLE | COM | 273.74K | SH | $10.78M 2.55% | 273.74K | 0.00 | 0.00 |
DAY ONE BIOPHARMACEUTICALS ISOLE | COM | 750.36K | SH | $10.45M 2.47% | 750.36K | 0.00 | 0.00 |
SYNDAX PHARMACEUTICALS INCSOLE | COM | 526.70K | SH | $10.14M 2.40% | 526.70K | 0.00 | 0.00 |
BIOHAVEN LTDSOLE | COM | 187.13K | SH | $9.35M 2.21% | 187.13K | 0.00 | 0.00 |
TANDEM DIABETES CARE INCSOLE | COM NEW | 204.21K | SH | $8.66M 2.05% | 204.21K | 0.00 | 0.00 |
KALVISTA PHARMACEUTICALS INCSOLE | COM | 723.68K | SH | $8.38M 1.98% | 723.68K | 0.00 | 0.00 |
NEUROCRINE BIOSCIENCES INCSOLE | COM | 69.61K | SH | $8.02M 1.89% | 69.61K | 0.00 | 0.00 |
KURA ONCOLOGY INCSOLE | COM | 408.37K | SH | $7.98M 1.89% | 408.37K | 0.00 | 0.00 |
VIKING THERAPEUTICS INCSOLE | COM | 125.62K | SH | $7.95M 1.88% | 125.62K | 0.00 | 0.00 |
EDGEWISE THERAPEUTICS INCSOLE | COM | 227.91K | SH | $6.08M 1.44% | 227.91K | 0.00 | 0.00 |
UROGEN PHARMA LTDSOLE | COM | 458.92K | SH | $5.83M 1.38% | 458.92K | 0.00 | 0.00 |
BIOCRYST PHARMACEUTICALS INCSOLE | COM | 667K | SH | $5.07M 1.20% | 667K | 0.00 | 0.00 |
ASCENDIS PHARMA A/SSOLE | NOTE 2.250% 4/0 | 4M | PRN | $4.68M 1.11% | 4M | 0.00 | 0.00 |
DEXCOM INCSOLE | COM | 65.55K | SH | $4.39M 1.04% | 65.55K | 0.00 | 0.00 |
Page 1 of 4